Devices › Tubes, vials, systems, serum separators, blood collection
Device brand name · Blood specimen collection device
BD Vacutainer CPT Cell Preparation Tube with Sodium Citrate: medical device reports filed with FDA
390 reports name it, 2018–2026. Manufacturer given most often on reports: Becton Dickinson & Broken Bow. Product code JKA.
- 390
- device reports naming the brand
- 0% of all MAUDE reports · about 47 a year
- 35
- reports, 12 months to August 2026
- 43 in the 12 months before
- 99.7%
- classified as malfunction
- 96.7% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
390 medical device reports received by FDA name the brand "BD Vacutainer CPT Cell Preparation Tube with Sodium Citrate" (blood specimen collection device); the manufacturer given most often on reports is Becton Dickinson & Broken Bow; received from April 2018 to July 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
35 reports arrived in the 12 months to August 2026, down 19% from 43 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.7%) and injury (0.3%); across all tubes, vials, systems, serum separators, blood collection reports (product code JKA) death is recorded in 0% and malfunction in 96.7%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are incorrect, inadequate or imprecise result or readings (33.1%), short fill (16.4%) and incorrect or inadequate test results (15.4%). The patient problems coded most often are no patient involvement and exposure to body fluids. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 49,074 reports carrying product code JKA. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Incorrect, inadequate or imprecise result or readings | 129 | 33.1% | 13.5% |
| Short fill | 64 | 16.4% | 16.1% |
| Incorrect or inadequate test results | 60 | 15.4% | 4.8% |
| Device ingredient or reagent problem | 39 | 10% | 4.8% |
| Breakthe device broke | 37 | 9.5% | 2.5% |
| Device contamination with chemical or other material | 28 | 7.2% | 10.9% |
| Volume accuracy problem | 27 | 6.9% | 5.8% |
| Leak/splashthe device leaked | 17 | 4.4% | 13.2% |
| Coagulation in device or device ingredient | 7 | 1.8% | 3.2% |
| Fluid/blood leak | 7 | 1.8% | 5.3% |
| Material deformation | 4 | 1% | 3.1% |
| Device markings/labelling problema problem with the device markings or label | 2 | 0.5% | 3.9% |
| Improper chemical reaction | 2 | 0.5% | 0.8% |
| Improper or incorrect procedure or method | 2 | 0.5% | 0.3% |
| Missing information | 2 | 0.5% | 0.4% |
| Clumping in device or device ingredient | 1 | 0.3% | 0.2% |
| Component missing | 1 | 0.3% | 1.2% |
| Crackthe device cracked | 1 | 0.3% | 1% |
| Delivered as unsterile product | 1 | 0.3% | 0.5% |
| Difficult to insertthe device was hard to insert | 1 | 0.3% | 1.4% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| No patient involvement | 2 | 0.5% |
| Exposure to body fluids | 1 | 0.3% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | BD Vacutainer CPT Cell Preparation Tube with Sodium Citrate | Product code JKA | All MAUDE reports |
|---|---|---|---|
| Reports | 390 | 49,074 | 26,136,888 |
| Share of that pool | — | 0.8% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 0.3% | 2.6% | 36.2% |
| Classified as malfunction | 99.7% | 96.7% | 62.3% |
| Filed by the manufacturer | 100% | 98.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code JKA
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about BD Vacutainer CPT Cell Preparation Tube with Sodium Citrate reports
How many FDA reports name BD Vacutainer CPT Cell Preparation Tube with Sodium Citrate?
390 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 35 in the latest 12 months.
What kinds of events are reported?
malfunction (99.7%) and injury (0.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
incorrect, inadequate or imprecise result or readings (33.1%), short fill (16.4%), incorrect or inadequate test results (15.4%), device ingredient or reagent problem (10%) and break (9.5%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that BD Vacutainer CPT Cell Preparation Tube with Sodium Citrate was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.